Rare diseases
Investigational molecules
Locations
138 conditions with trials, the busiest first
373 trials across Europe, recruiting first
Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
FranceStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
FranceComparing diclofenac sodium eye drops versus dexamethasone phosphate eye drops for recovery after vitrectomy in patients with macular disorders
BelgiumStudy of sublingual immunotherapy with Phleum pratense pollen extract spray in patients with moderate to severe grass pollen allergic rhinitis
GermanyStudy of CLU-RX-PHL injection therapy for patients with moderate to severe grass pollen allergy to find the most effective and safe dose
GermanyStudy on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema
AustriaStudy on the Safety and Effectiveness of VRDN-001 for Patients with Thyroid Eye Disease
FranceStudy on Goblet Cell Density in Patients with Ocular Hypertension or Primary Open Angle Glaucoma Using Benzalkonium Chloride and Latanoprost Eye Drops
DenmarkStudy on Reducing Eye Prosthesis Discomfort and Discharge Using Retinol Palmitate, Sodium Hyaluronate, and Fluorometholone for Patients with Chronic Symptoms
The NetherlandsStudy on the Safety and Tolerability of VRDN-003 for Patients with Thyroid Eye Disease
FranceStudy on the Use of SB11 Pre-Filled Syringe for Patients with Wet Age-Related Macular Degeneration, Macular Edema from Retinal Vein Occlusion, or Myopic Choroidal Neovascularization
PolandStudy of sublingual birch pollen extract (SLI-RX-BET) in different doses for patients with moderate to severe allergic rhinitis caused by birch pollen
GermanyThe therapies tested most often in Eye disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
